Author(s): Kaur G, Narang RK, Rath G, Goyal AK, Kaur G, Narang RK, Rath G, Goyal AK, Kaur G, Narang RK, Rath G, Goyal AK, Kaur G, Narang RK, Rath G, Goyal AK
Abstract Share this page
Abstract Nanotechnology has potential in the development of novel and effective delivery of drugs within lungs. Different strategies have been utilized for pulmonary delivery of drugs, including the use of lipid-based delivery systems (liposomes, ISCOMs, SLNs), use of polymeric matrix (PLGA, poly caprolactone, cynoacrylates, gelatin), development of polysaccharide particulates (chitosan, alginates, Carbopol, etc.), biocompatible metallic inorganic particles (iron, gold, zinc), etc. This paper reviews various nanopaticulate approaches in the form of lipids, polymers, metals, polysaccharides, or emulsions based for pulmonary drug delivery that could provide an increased biological efficacy and better local and systemic action.
This article was published in Artif Cells Blood Substit Immobil Biotechnol
and referenced in Journal of Nanomedicine & Biotherapeutic Discovery